Skip to main content
Premium Trial:

Request an Annual Quote

Mapmygenome India Launches, Partners with Brain Resource

NEW YORK (GenomeWeb News) – Personal genomics firm Mapmygenome India launched on Tuesday with the announcement of a partnership with Brain Resource.

The Hyderabad, India-based company offers services including a personal genetic profiling product called Genomepatri which includes information about traits, diseases, and drug responses based on an individual's DNA sample.

In partnership with Brain Resource, Mapmygenome also is offering a product called Mapmybrain for brain wellness. Mapmybrain comprises two solutions, WebNeuro for assessing an individual's cognitive strengths and weaknesses, and MyCalmBeat, a personal stress reduction monitor.

Brain Resource is a cognitive tool development shop with offices in San Francisco and Ultimo, Australia.

"With 12 years of expertise in the genomics space, we felt it was time to bring personal genomics to India," Anu Acharya, CEO of Mapmygenome, said in a statement. "With our products and services, we hope to make a positive impact on the early detection of life threatening diseases and conditions."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.